Bing
- Novartis making cell-based flu vaccine in U.S.
- With demand high because of the swine flu pandemic, companies are trying to find a more efficient way of producing vaccine than the slow method of cultivating seed virus in chicken eggs. Novartis said once the plant is in full operation it
- Chicago Tribune
- ·
- 3 hours ago
- AVI BioPharma, Inc. to Present at Transformational Medical ...
- AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today announced that Patrick Iversen, Ph.D., Senior Vice President of Strategic Alliances, will present at the upcoming Transformational Medical Technologies Initiative
- Stockhouse
- ·
- 11/18/2009
- AVI BioPharma, Inc. Presents Update on AVI-4658 at TREAT-NMD /
- AVI's antiviral programs have demonstrated promising outcomes in Ebola Zaire and Marburg Musoke virus infections and may prove applicable to other viral targets such as Junin, influenza, HCV or Dengue viruses. For more information, visit
- Stockhouse
- ·
- 11/19/2009
- Novartis Teams Up With the US for Vaccines
- The latest technology in vaccine production just got a little closer to home. On Tuesday, Novartis ( NVS ), the third-largest pharmaceutical company in the world by market cap, announced the inauguration of the first US-based large-scale
- Minyanville
- ·
- 11 hours ago
- US plant for cell-based flu vaccines opens in NC
- BASEL, Switzerland (AP) - Swiss pharmaceuticals maker Novartis AG has opened the first U.S. plant to produce flu vaccines using cell cultures instead of egg-based methods, it said Tuesday. The new site in Holly Springs, North Carolina, is
- Charleston Daily Mail
- ·
- 13 hours ago
- Novartis unveils US cell-based flu vaccine plant
- Nov 24, 2009 (CIDRAP News) – The era of cell-based influenza vaccine production in the United States seemed to move closer today as Novartis unveiled its new, nearly billion-dollar manufacturing plant in Holly Springs, N.C., but onshore
- Centre For Infectious Disease Research and Policy
- ·
- 5 hours ago
- Novartis opens Holly Springs flu vaccine plant
- Posted: Today at 6:05 a.m. Updated: Today at 3:33 p.m. Holly Springs, N.C. — Swiss pharmaceuticals maker Novartis AG (NYSE: NVS ) opened the doors Tuesday at its first U.S. plant to produce flu vaccines using cell cultures instead of
- WRAL
- ·
- 9 hours ago
- Novartis opens new flu vaccine plant in US
- HOLLY SPRINGS, North Carolina (Reuters) - The bioreactors are empty and running just for show for now, but Novartis opened its first U.S. flu vaccine plant Tuesday, the first in the country to make flu vaccines out of cells instead of eggs.
- CNN Money
- ·
- 11 hours ago
- Novartis opens plant for cell-based vaccine in NC
- ... of the swine flu pandemic, companies are trying to find a more efficient way of producing vaccine than the slow method of cultivating seed virus in chicken eggs. Novartis said once the plant is in full operation it will be able to
- Charleston Daily Mail
- ·
- 16 hours ago
- Plant for cell-based flu vaccines opens in N.C.
- BASEL, Switzerland (AP) — Swiss pharmaceuticals maker Novartis AG has opened the first U.S. plant to produce flu vaccines using cell cultures instead of egg-based methods, it said Tuesday. The new site in Holly Springs, North Carolina, is
- Greensboro News & Record
- ·
- 13 hours ago